Suchergebnisse - "Zhou, Lin"

PubPharm (56)

1

Precision medicine in colorectal cancer : Leveraging multi-omics, spatial omics, and artificial intelligence

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2024

von Xu, Z. | Li, W. | Dong, X. | +5

2

Protective effects of sodium butyrate on fluorosis in rats by regulating bone homeostasis and serum metabolism

enthalten in: Ecotoxicology and environmental safety | 2024

von Li, Y. | Yang, F. | Liu, J. | +6

3

Monitoring of Sweat Ions and Physiological Parameters via a Reconfigurable Modular System

enthalten in: ACS sensors | 2024

von Lin, B. | Sun, T. | Hui, J. | +4

4

Chinese expert consensus statement on the clinical application of AFP/AFP-L3%/DCP using GALAD and GALAD-like algorithm in HCC

enthalten in: Journal of clinical laboratory analysis | 2023

von Huang, C. | Xiao, X. | Zhou, L. | +48

5

2022 White Paper on Recent Issues in Bioanalysis : ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs (

enthalten in: Bioanalysis | 2023

von Szapacs, M. | Jian, W. | Spellman, D. | +83

6

2022 White Paper on Recent Issues in Bioanalysis : FDA Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, LNP & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolongation Effect, ADA Affinity, Risk-based Approaches, NGS, qPCR, ddPCR Assays (

enthalten in: Bioanalysis | 2023

von Pan, L. | Mora, J. | Walravens, K. | +66

7

The circadian rhythm key gene ARNTL2 : a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers

enthalten in: Frontiers in immunology | 2023

von Wu, G. | Ren, H. | Hu, Q. | +5

8

ATP5D Is a Potential Biomarker for Male Fertility

enthalten in: Oxidative medicine and cellular longevity | 2023

von Wang, Y. | Zhai, C. | Yao, G. | +5

9

The SNHG1-Centered ceRNA Network Regulates Cell Cycle and Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma

enthalten in: The Tohoku journal of experimental medicine | 2022

von Zhou, L. | Zhang, Q. | Deng, H. | +3

10

CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis

enthalten in: Journal of experimental & clinical cancer research : CR | 2022

von Jiang, Y. | Zhao, J. | Li, R. | +6

ErratumIn: J Exp Clin Cancer Res. 2022 Nov 10;41(1):320. - PMID 36352462

1
2
3
4
5
6
Nächster »
[6]